Lausten Dalby

  • A phase II study was conducted to evaluate the safety and efficacy of preoperative, intra-arterial perfusion of epirubicin, etoposide, and oxaliplatin combined with oral chemotherapy S-1 (SEEOX) for the treatment of type 4 gastric cancer.

    A single-center, single-arm phase II trial was conducted on 36 patients with histologically proven…[Read more]

  • Lausten Dalby became a registered member 6 hours, 45 minutes ago